Appendix C
Speaker Biographical Sketches
Beth Bafford, M.B.A., joined Calvert Foundation in early 2014 to work on strategy, partnership development, fundraising, and capital deployment for current and future initiatives. Her main areas of focus are rebuilding iconic American cities and global health, but she also works on issues across Calvert Foundation’s portfolio. Prior to joining Calvert Foundation, Ms. Bafford was a consultant in McKinsey & Company’s Washington, DC, office where she focused mostly on U.S. health reform strategy for large health insurers and hospital systems. She has also worked as a special assistant at the White House Office of Management and Budget during the drafting and passage of the Affordable Care Act, as a regional field director for the 2008 Obama for America campaign, and as a senior associate at UBS Financial Services.
Ms. Bafford earned both her B.A. in Public Policy and M.B.A. in Social Entrepreneurship from Duke University. At Duke’s Fuqua School of Business, she helped launch the CASE Initiative on Impact Investing (CASE i3).
David M. Barash, M.D., is the executive director of the Global Health Portfolio and chief medical officer for the GE Foundation. The Foundation’s Developing Health Initiatives, along with strong partnerships and leaders, are often the answer to some of health care’s most complex problems.
Dr. Barash is a practicing emergency medicine physician with more than 30 years’ experience. He has focused a great deal on understanding
how new technologies can be commercialized and delivered to effectively close the gap between brainstorm and bedside.
Prior to joining the GE Foundation, Dr. Barash was the chief medical officer of Life Care Solutions and executive medical director of Health Care Services for GE Healthcare. He was also founder and president of Concord Healthcare Strategies, where he provided strategic and operational expertise to medical technology investors and development-stage medical technology companies. Dr. Barash is a graduate of Cornell University and the author of several clinical publications.
Aron Betru, M.B.A., M.A., is the managing director of the Center for Financial Markets at the Milken Institute, with more than 15 years of experience in strategic and structured financial execution, he is a known leader in the innovative financing space. Mr. Betru will be leading strategic initiatives at CFM, where he will be exploring practical ways and models to increase and better leverage resources to social impact areas, both in the United States and in developing countries. His mandate, in part, will be to brainstorm ways to “take the next step” beyond where think tanks traditionally stop, into areas of execution and implementation. In this capacity he’ll be working across the organization as well as with our external partners.
Prior to the Milken Institute, Mr. Betru was the co-founder and chief executive officer at Financing For Development, a DC-based nonprofit that specialized in innovative financing solutions for international development, Mr. Betru pioneered new ways of leveraging guarantee-backed financing of public health commodities, mobilizing millions of dollars in both commercial lending for malaria and trade financing for reproductive health.
Mr. Betru is a member of the Council on Foreign Relations and a regular contributor to the Global Health and Diplomacy magazine writing on innovative finance in public health as well as a contributor to the global dialogue on pandemic financing with speaking engagements at the National Academy of Sciences and Voice of America Interviews. He holds an M.B.A. from Columbia University, an M.A. from Johns Hopkins SAIS, and a B.A. in Economics and International Studies from Northwestern University.
Paurvi Bhatt, M.P.H., is the senior director for global access at Medtronic Philanthropy, where she leads a multimillion-dollar global strategic grants portfolio that focuses on empowering people impacted by NCDs (noncommunicable diseases), enabling frontline health workers, and advancing policy dialogue to increase access to care for the underserved. She is a seasoned global health leader with deep multisectoral experience in
the business, nonprofit, and government sectors. She spearheaded global programs at several private companies, including Levi Strauss and Co. and Abbott. Ms. Bhatt has also managed global health technical portfolios at the U.S. Agency for International Development (USAID) and CARE USA. She has also served as an international evaluator at the U.S. General Accountability Office. Her technical expertise is in HIV/AIDS, women’s health, and health systems and economics. She serves on several human resources organizations, international health and HIV/AIDS working groups, technical advisory committees, and several Boards, including the Global Business Group on Health, AIDSUnited, and GlobeMed. She holds an M.P.H. in Health Systems and Economics from Yale University and a bachelor’s degree in Neuroscience from Northwestern University.
Brenda D. Colatrella, M.B.A., is executive director of Corporate Responsibility (CR) within Global Public Policy & Corporate Responsibility at Merck & Co., Inc., a central function that coordinates the development, implementation and reporting of Merck’s global corporate responsibility approach on environmental, social, ethical and governance issues in support of the company’s business strategy. She also oversees several of Merck’s global health partnerships and relationships with key partners and is involved in the development of policies that help to expand access to medicines, vaccines and quality health care particularly in the developing world and emerging markets. Ms. Colatrella also serves as president of the Merck Foundation, a U.S.-based private charitable foundation established in 1957 that is funded entirely by Merck and is Merck’s chief source of funding support for qualified nonprofit charitable organizations.
Prior to assuming this position, Ms. Colatrella was executive director, Global Health Partnerships, within the Office of Corporate Responsibility, responsible for key global health and access partnerships and Merck’s relationships with a wide range of stakeholders in the global health arena. She also held the position of executive director, HIV Policy and External Affairs for the Europe, Middle East, Africa, Canada region, with a primary focus on driving Merck and industry initiatives to improve access to HIV/AIDS care and treatment in the developing world, and was senior vice-president, The Merck Foundation, and senior director, Office of Contributions, responsible for all Foundation and corporate cash grant making activities, product donations programs (e.g., the Merck Mectizan Donation Program). Ms. Colatrella received her B.A. from Muhlenberg College, summa cum laude, Phi Beta Kappa, and her M.B.A. from New York University’s Stern School of Business where she was the recipient of the Dean’s Award. She has published several articles on the Mectizan Donation Program, the role of the private sector in global health, and successful public–private partnership.
Abby Davidson Maffei, M.P.A., M.A., has more than 10 years of experience creating bold partnerships with business, government, and civil society to address complex social issues. At CARE USA, she leads a team partnering with global companies to develop supply and distribution models that fight poverty and empower women and girls, while improving the bottom line. Ms. Davidson Maffei and her team also engage companies in philanthropy, marketing and consumer engagement, government relations/advocacy, and employee engagement. Her team manages partnerships in the following industries: food, beverage, and agriculture; financial services; consumer products; and health and pharmaceuticals. During her time at CARE, Ms. Davidson Maffei was also based in Johannesburg, South Africa, where she developed a regional private-sector engagement strategy with seven country offices. Prior to joining CARE, Ms. Davidson Maffei worked at the Washington, DC-based Ethics Resource Center, where she consulted with global organizations to design, implement, and evaluate ethics and compliance programs. She started her career in the office of U.S. Representative Sander Levin (D-MI), and has experience with five congressional campaigns. She holds a Master of International Relations from the Johns Hopkins School of Advanced International Studies, a Master of Public Administration from the Maxwell School at Syracuse University, and a B.A. from Brown University.
Victor J. Dzau, M.D., is the president of the National Academy of Medicine. In addition, he serves as chair of the Health and Medicine Division Committee of the National Academies of Sciences, Engineering, and Medicine. He is Chancellor Emeritus and James B. Duke Professor of Medicine at Duke University and the past president and CEO of the Duke University Health System. Previously, Dr. Dzau was the Hersey Professor of Theory and Practice of Medicine and chairman of Medicine at Harvard Medical School’s Brigham and Women’s Hospital as well as chairman of the Department of Medicine at Stanford University.
Raymond J. Fabius, M.D., has recently returned to his start-up HealthNEXT—a company dedicated to the development of organizational cultures of health—after serving as chief medical officer of Truven Health Analytics (formerly the health care business of Thomson Reuters), the world’s leading source of intelligent information for business and professionals. In this capacity he is charged with developing and deepening relationships with customers, advising on product development, and providing counsel to the leadership on business strategy and medical issues. Formerly, Dr. Fabius served as strategic advisor to the president of the Walgreens Health & Wellness Division.
Dr. Fabius is the principal of Ab3Health LLC, an organization focused
on population health, health and productivity, and building organizational “cultures of health.” To accomplish these goals, Ab3Health uses the five-stage roadmap advocated by the American College of Occupational and Environmental Medicine as well as Six Sigma methodology. During the assessment process, organizations are compared to benchmarks to determine gaps, which are then prioritized in an implementation plan to achieve best practice.
Dr. Fabius was I-trax (AMEX:DMX)/CHD Meridian’s president and chief medical officer for the 3 years prior to its sale to Walgreens. During this tenure he served on the Board of Directors and was principally responsible for converting this financially struggling organization into a workplace health leader while quadrupling the DMX market capitalization. CHD Meridian operated more than 300 workplace health centers, providing fitness centers, wellness programming, occupational health, acute episodic illness treatment, and comprehensive primary care and pharmacy services. Leveraging the trusted clinician at the workplace™ I-trax integrated wellness, disease, and disability management programs within the proven advantaged on-site model. In his role Dr. Fabius provided visionary guidance, new product development, clinical leadership, setting of the research and development agenda.
Alyson Genovese, M.B.A., is Global Reporting Initiative’s (GRI’s) head of corporate and stakeholder relations for the United States and Canada. GRI is an international, independent organization that helps businesses, governments, and other organizations to understand and communicate the impact of business on critical sustainability issues such as climate change, human rights, corruption, and many others. With thousands of reporters in more than 90 countries, GRI provides the world’s most trusted and widely used standards for sustainability reporting and disclosure.
Ms. Genovese is an accomplished professional in the corporate and nonprofit sectors, with more than 20 years of experience in corporate social responsibility, public affairs, corporate citizenship, sustainability communications, and stakeholder engagement. Her broad range of experience as an internal executive, freelance consultant, and trusted advisor makes her an ideal partner for GRI’s local stakeholders within North America.
Ron Goetzel, Ph.D., wears two hats. He is a senior scientist and director of the Institute for Health and Productivity Studies (IHPS) at the Johns Hopkins Bloomberg School of Public Health as well as vice president of consulting and applied research for Truven Health Analytics. The mission of IHPS is to bridge the gaps among academia, the business community, and the health care policy world—bringing academic resources into policy
debates and day-to-day business decisions, and bringing health and productivity management issues into academia. Before moving to Hopkins, Dr. Goetzel was on the faculty at Emory and Cornell Universities. Dr. Goetzel is responsible for leading innovative projects for health care purchaser, managed care, government, and pharmaceutical clients interested in conducting cutting-edge research focused on the relationships among health and well-being, medical costs, and work-related productivity. He is an internationally recognized and widely published expert in health and productivity management (HPM), return-on-investment (ROI), program evaluation, and outcomes research. Dr. Goetzel has published well over 200 peer-reviewed articles and book chapters and frequently presents at international business and scientific forums.
Clarion Johnson, M.D., served as Global Medical Director of ExxonMobil Corporation until his retirement in 2013. Currently, Dr. Johnson is a consultant to ExxonMobil, the chair of The Joint Commission’s International and Resource Boards and a member of The Yale School of Public Health Leadership Council. He serves on several boards including the The Bon Secours Hospital System; the Advisory Board of The Yale School of Public Health; the Board on Global Health of the Institute of Medicine, and co-chairs its Forum on Public Private Partnerships for Global Health and Safety. Dr. Johnson also has a U.S. Department of Health and Human Services Secretary appointment to the NIOSH (National Institute of Occupational Safety and Health) Advisory Board and was a member of Virginia Governor’s Task Force on Health reform and co-chair, Insurance Reform Task Force. He is the past chair of Virginia Health Care Foundation, and the Board of City Lights Charter School in Washington, DC. He served as advisor and lecturer in the Harvard Medical School’s department of continuing education “Global Clinic Course” 2005–2008. In 2013 he received the President’s Award from the Oil and International Petroleum Industry Environment Conservation Association (IPIECA) and Oil and Gas Producers (OGP) for contributions to health and in 2012, he was the recipient of the Society of Petroleum Engineers (SPE) Award for Health, Safety, Security, Environment and Social Responsibility. In 2011, he received a medal from the French Army’s Institute De Recherche Biomedical for “Project Tetrapole:” a public–private partnership in malaria research. Dr. Johnson is a graduate of Sarah Lawrence College and member of its Board of Trustees and the Yale School of Medicine. While on active duty in the U.S. Army, he also trained as a microwave researcher at Walter Reed Army Institute of Research. He is board certified in internal medicine, cardiology and occupational medicine.
Mehmood Khan, M.D., is vice chairman and chief scientific officer of PepsiCo. In his role, Dr. Khan oversees the PepsiCo global Performance with Purpose sustainability agenda, including environmental, agriculture, energy, and water as well as human and talent sustainability for the company. He leads PepsiCo’s research and development (R&D) efforts, creating breakthrough innovations in food, beverages, and nutrition—as well as delivery, packaging, and production technology—to drive PepsiCo’s businesses forward. Before joining PepsiCo in 2007, Dr. Khan was president, Takeda Global Research & Development Center, overseeing Takeda Pharmaceuticals Company’s worldwide drug development. Earlier, he was a consultant endocrinologist and faculty member at the Mayo Clinic and Mayo Medical School, also serving as the director of the Diabetes, Endocrine, and Nutritional Trials Unit in the division of endocrinology. Prior to the Mayo Clinic, he spent 9 years leading programs in diabetes, endocrinology, metabolism, and nutrition, including as chief of endocrinology for the Hennepin County Medical Center in Minneapolis, University of Minnesota. He has served as faculty both in the department of Food Sciences, College of Agriculture and the Medical School at the University of Minnesota. Dr. Khan serves as a member of the Board of Governors of the New York Academy of Sciences and on several national committees. His work has been recognized by numerous industry awards.
Mark Kramer, M.B.A., J.D., leads FSG, a 150-person nonprofit consulting firm, working from six offices in Asia, Europe, and the United States to devise social impact strategies for many of the world’s largest foundations, corporations, and nonprofit organizations.
Mr. Kramer also serves as a senior fellow at Harvard’s Kennedy School of Government. He co-founded the Center for Effective Philanthropy; served on the jury of the annual Excellence in Corporate Philanthropy Award; is a member of the Aspen Philanthropy Group and the Kimberly-Clark Sustainability Advisory Board; serves on the planning committee for the Clinton Global Initiative; and lectures in the Executive Education Program of Harvard Business School.
Mr. Kramer has published extensively on topics in philanthropy, collective impact, evaluation, and creating shared value. He has co-authored many influential articles in the Harvard Business Review with Professor Michael E. Porter of Harvard Business School, and in Stanford Social Innovation Review with FSG colleagues, including Philanthropy’s New Agenda: Creating Value, Catalytic Philanthropy, Collective Impact, Strategic Philanthropy for a Complex World, The Competitive Advantage of Corporate Philanthropy, and Creating Shared Value.
Prior to founding FSG, Mr. Kramer served as president of Kramer Capital Management. He is a graduate of Brandeis University, The Wharton School, and the University of Pennsylvania Law School.
Paula Luff is founder and CEO of Viso Strategies Corporation. She was vice president of Corporate Social Responsibility for Hess Corporation, a global integrated energy company based in New York City, until December 2015.
Ms. Luff established and leads formal social responsibility and philanthropy functions for the company. Prior to joining Hess, she was senior director of Global Philanthropy for Pfizer Inc., where she set strategy and led the teams that developed flagship programs in global health for the company and its foundation: the International Trachoma Initiative, the Diflucan Partnership, Global Health Fellows, the Infectious Diseases Institute, Connect HIV, Community Health Ventures and Regional Health Partnerships. She also represented Pfizer on philanthropy and global health issues with the media, public officials, bilateral and multilateral organizations, and other external stakeholders. Ms. Luff was previously with CARE, the humanitarian organization fighting global poverty.
Ms. Luff holds a bachelor’s degree from the University of Wisconsin and master’s degrees from New York University and the New School University. She serves on the boards of Philanthropy New York and the UN Global Compact U.S. Network Steering Committee. She has served on the boards of Grantmakers in Health and Accordia (formerly the Academic Alliance Foundation for AIDS Care and Prevention in Africa).
Nancy Mahon, ESQ, is senior vice president, Global Philanthropy and Corporate Citizenship, for The Estée Lauder Companies and global executive director of the MAC AIDS Fund. In this role, she is responsible for Estée Lauder’s global corporate citizenship strategy, encompassing all philanthropic, cause-marketing, employee engagement, and product donation programs. Ms. Mahon also oversees the strategic direction and day-to-day operation of the MAC AIDS Fund. Currently, the Fund gives away $44 million annually throughout the world, particularly in the 72 countries in which MAC has affiliates.
In December 2011, Ms. Mahon was appointed as the chair of the Presidential Advisory Council on HIV/AIDS (PACHA). PACHA provides advice and recommendations to the President and the Secretary of Health and Human Services on programs and policies intended to promote effective prevention of HIV disease, and to advance research on HIV disease and AIDS.
Prior to joining MAC in June 2006, she was executive director of God’s Love We Deliver (GLWD), the nation’s oldest and largest provider
of life-sustaining nutritional support services for people living with HIV/AIDS, cancer and other serious illnesses.
Ms. Mahon is a magna cum laude graduate of Yale University and New York University’s School of Law, where she was an editor of the Law Review.
Ali Mokdad, Ph.D., is director of Middle Eastern Initiatives and professor of Global Health at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. In this role, he is building IHME’s presence in the region through new research projects, dissemination and uptake of IHME’s methods and results, and consultation with regional leaders in population health. He also leads the survey and surveillance activities at IHME with his expertise in survey methodology, health surveys, surveillance, chronic diseases, and emergency and response.
Prior to joining IHME, Dr. Mokdad worked at the Centers for Disease Control and Prevention. He served in numerous positions with the International Health Program; the Division of Nutrition and Physical Activity; the National Immunization Program; and the National Center for Chronic Diseases Prevention and Promotion, where he was chief of the Behavioral Surveillance Branch.
Cate O’Kane is the director of Corporate Partnerships & Philanthropy at Population Services International (PSI), headquartered in Washington, DC. At PSI she leads the development of philanthropic, corporate social responsibility, and shared value partnerships, integrating the worlds of both purpose and profit to deliver win–win opportunities across sectors. Using a model focused on private-sector efficiencies, PSI works across 70 countries to make it easier for women and their families to access the health care and services they need. Prior to joining PSI in DC, Ms. O’Kane was the technical services director at PSI/Botswana, where she led the platform’s marketing, communications, and research programs across a multitude of HIV/AIDS interventions. She spent 16 years working in Europe and Asia, most recently as the director of JWT’s (J. Walter Thompson’s) North East Asia team, expanding market share for companies in this dynamic region.
Marjorie Paloma, M.P.H., who leads the Robert Wood Johnson Foundation’s efforts in engaging business for health, believes the Foundation is uniquely positioned to leverage research, investments, leadership, relationships, and networks to create timely and enduring social change.
Most recently, she played an integral role in coordinating and supporting the Foundation’s strategic thinking efforts, which defined direction in 2014. Throughout her tenure at the Foundation, Ms. Paloma’s work
has focused on laws and policies to improve health, with an emphasis on childhood obesity, tobacco control, and other population health issues. Her portfolio includes working with businesses, policy makers, community leaders, and stakeholders to support actions that make it easier for people to make healthy choices in the communities where they live, learn, work, and play.
Prior to joining the Foundation, Ms. Paloma managed the Wisconsin Tobacco Quit Line at the University of Wisconsin–Center for Tobacco Research and Intervention, where she designed and implemented ways to help people quit tobacco use. Prior to that, she staffed the Wisconsin Tobacco Control Board, an 18-member Governor-appointed board. In this capacity she provided guidance in the development of the state tobacco control strategy and organized and coordinated the state and local policy advocacy efforts. She believes this experience showed her how bringing diverse partners to the table can create the power and influence to achieve enduring change. Ms. Paloma earned an M.P.H. in Sociomedical Sciences from the Columbia University Mailman School of Public Health and a B.A. in Biology from the College of Notre Dame of Maryland.
Bart Peterson, J.D., joined Eli Lilly and Company in 2009 as senior vice president of corporate affairs and communications. He is a member of the company’s executive committee. Mr. Peterson received a bachelor’s degree from Purdue University and earned his J.D. at the University of Michigan.
From 2000 to 2007, Mr. Peterson served two terms as mayor of Indianapolis, the nation’s 12th largest city. He also served as president of the National League of Cities in 2007. As mayor, along with Indiana University, Purdue University, Lilly, and the Central Indiana Corporate Partnership, he created BioCrossroads, a focused effort to push Indianapolis to the forefront as a life sciences capital. Prior to joining Lilly, Mr. Peterson was managing director at Strategic Capital Partners, LLC, from 2008 to 2009. In early 2008, Mr. Peterson was a fellow with the Institute of Politics of Harvard University’s Kennedy School of Government. During the 2008–2009 school year, he was a distinguished visiting professor of Public Policy at Ball State University. In addition, he is a member of the Indiana University School of Public and Environmental Affairs Dean’s Council. In 2012, Mr. Peterson was appointed by the U.S. Department of State to the Asia–Pacific Economic Cooperation Business Advisory Council.
Kyle Peterson has managed more than 100 consulting projects for FSG in the areas of strategy, program design, operations, and evaluation. He speaks frequently at social sector and industry conferences and roundtable events. Mr. Peterson has worked with the world’s leading companies
and funders, including Shell Oil Company, Aetna, Eli Lilly and Company, Pfizer Inc., Verizon, Merck, and The Bill & Melinda Gates Foundation. He is currently a member of the Global Health Council’s Board of Directors.
Building on more than 25 years of international development experience, Mr. Peterson has led many of FSG’s Global Health and Global Development engagements, and he has been a key contributor to the firm’s shared value, catalytic philanthropy, and collective impact frameworks.
Prior to joining FSG, Mr. Peterson served as a strategy consultant at the Monitor Group, where he wrote a major regional economic study with Professor Michael Porter and led a competitiveness consulting project for President Paul Kagame and his cabinet on Rwanda’s economic strategy. Mr. Peterson was also a country director in Zimbabwe and Rwanda for Population Services International, where he managed a $20 million program and launched a number of health product “firsts” on the African continent, including mass-marketed, insecticide-treated mosquito nets, female condoms, and a novel network of HIV/AIDS voluntary counseling and testing centers.
Joy Phumaphi is the executive secretary of the African Leaders Malaria Alliance, a member of the United Nations Secretary General’s High-Level Panel on the Global Response to Health Crises, and chair of the Global Leaders Council for Reproductive Health. She served as member of Parliament in Botswana, holding portfolio responsibility in the cabinet, first for Lands and Housing, and then for Health. She later joined the World Health Organization as assistant director general for family and community health. She has served as vice president for human development at the World Bank. She has also served on a number of commissions and expert groups and sits on the Boards of several international nonprofit organizations working on global health.
John Sargent, M.D., is recognized globally as a health care solutions thought leader in market development strategy, health systems analytics and optimization, and public–private partnerships in emerging markets. Dr. Sargent consults to governments, multinational companies, and donor organizations. He is a popular keynote speaker at industry conferences. A member of the Board of Directors of the Fulbright Association, he was also nominated to the Devex Top 40 Under 40 Leaders in Development in 2010–2011 and recognized as a Social Entrepreneur for 2015 by the World Economic Forum and the Schwab Foundation.
Dr. Sargent co-founded BroadReach in 2003 and led the development of its global health work, securing significant contracts with the U.S. Agency for International Development (USAID): a $100 million contract for South Africa; the Kenya USAID APHIA II Western project; the USAID
Strengthening Pharmaceutical Systems program; the USAID AIDSTAROne project; and the Management and Leadership Training Program in Zambia. He also works closely with global life science companies and spearheads the company’s analytics business.
Prior to co-founding BroadReach, Dr. Sargent consulted on strategic and operational issues related to multiple disease areas for public and private organizations in developed and emerging markets. He earned an undergraduate degree from Dartmouth College, a master’s degree from Oxford University as a Fulbright Scholar, and an M.D. from Harvard Medical School.
Sanjay Sehgal is the vice president, Nutrition, Health and Wellness (NHW) for Nestlé Ltd. in the United States, responsible for driving the NHW agenda across all of the Nestlé businesses in the country. Mr. Sehgal began his Nestlé career in 1989 as part of the Nestlé India marketing team. He was named communication director for the South Asia region in 1996, and in 1999 was promoted to marketing director for Nestlé India, responsible for brand and business development and marketing communications across the entire product portfolio. In 2002, the company moved Mr. Sehgal to its headquarters in Switzerland as head of Nutrition Communications and Health Initiatives to work in the core team, driving the company’s strategic evolution to being the leading nutrition, health, and wellness company. In 2006 he was named global head of the Meals & Drink business. In 2009, he became vice president and head of the Corporate Wellness Unit, responsible for driving the company’s strategies toward greater nutrition, health, and wellness leadership. In 2014, he moved to the United States as vice president of NHW for Nestlé Ltd. USA.
Frederic Sicre, M.B.A., has more than 20 years of experience in engaging the private sector on global issues, regional development agendas, and community building. He is a managing director in the Global Markets team and works with leaders from all fields, including governments, private sector, media, and culture.
Prior to joining the group, Mr. Sicre spent 16 years as managing director and member of the Executive Board at the World Economic Forum, where he first established the Forum’s activities in Africa and the Middle East. Mr. Sicre was responsible for the Center for Regional Strategies, with a particular focus on global growth markets and the Annual Meeting in Davos, Switzerland. He also served as editor of South Africa at Ten, a book celebrating the first 10 years of democracy in the country.
Mr. Sicre is the chair of the Mustaqbali Foundation and serves on the Board of Dubai Cares and Education for Employment and Junior Achievement’s MENA Board. He is also a member of the United Nations
Global Compact Business for Peace Steering Committee and is a member of the World Presidents’ Organization. Mr. Sicre holds a bachelor of arts and sciences from Villanova University and an M.B.A. from International Institute for Management Development (IMD), and is a fellow of Stanford University.
Lori Stetz, M.D., M.P.H., is the senior medical director for Aetna International. Prior to joining Aetna, she practiced primary and urgent care medicine and public health in Connecticut and a number of international settings, including Kosovo, Nepal, and Thailand.
Dr. Stetz graduated from Haverford College, and holds an M.P.H. from Boston University and an M.D. from SUNY Downstate Medical Center. She is certified by the American Board of Family Medicine and has special certification in Travel Medicine.
Wendy Taylor, M.P.P., is director of the Center for Accelerating Innovation and Impact at the U.S. Agency for International Development (USAID), a center of excellence applying innovative, business-minded approaches to accelerate the development, introduction and scale-up of priority global health innovations. Joining the agency in 2010, Ms. Taylor created and built the Center; spearheaded several Grand Challenges to globally crowd source groundbreaking solutions to tough health challenges, including the successful Saving Lives at Birth and Fighting Ebola Grand Challenges; and created multiple public–private partnerships.
She has worked for the past 20 years identifying market-based solutions to address diseases and conditions of poverty. In 2004, she founded Bio Ventures for Global Health (BVGH), a nonprofit working to engage the biopharmaceutical industry to develop medicines for diseases of the developing world. She also held senior positions with Malaria No More and the Biotechnology Industry Organization (BIO), and worked in both the executive and legislative branches of the U.S. government, including the Office of Management and Budget and the U.S. House Committee on Ways and Means.
She received a Master of Public Policy from the Kennedy School of Government at Harvard University and a B.A. from Duke University. She serves on the North American Board of Medicines for Malaria Ventures and is Chair of HANSHEP, an international donor coordinating body harnessing the private sector to deliver better health care to the poor.
Brett Tromp is a qualified chartered accountant and has been the chief financial officer of Discovery Health since 2007. Prior to this role he worked for the group executive director on strategic projects and in the group finance area of Discovery Holdings for 3 years.
Mr. Tromp has been with Discovery since 2003 and has vast experience in the health insurance industry. Mr. Tromp also has experience in treasury, due diligence, and financial modeling. He has significant international health insurance exposure, obtained during his travels into Africa, the United States, the United Kingdom, and Europe. Mr. Tromp has lived in the United States and has audited major Fortune 500 companies such as GE.
In 2013, Mr. Tromp completed a year’s course at Oxford University on business strategy. He is a director at Discovery’s third-party recovery services subsidiary and has recently been given the responsibility to lead Discovery’s new pharmacy business, SRX. Mr. Tromp also chairs and sits on various NPO finance committees. He has been a keynote speaker around the world and is a regular monthly writer for Accountancy SA monthly magazine. He regularly deals with governments in Africa and is spearheading change in corporate reporting to include health metrics in company reports.
In 2015 Mr. Tromp was named as South Africa’s young (under 40) chief financial officer of the year, as well as the award for the best high performing finance team in South Africa.
Jane Wales has been president and CEO of the World Affairs Council of Northern California since 1998. Ms. Wales is also president and co-founder of the Global Philanthropy Forum; vice president, Philanthropy and Society; and director of the Program on Philanthropy and Social Innovation at the Aspen Institute. She is host of the nationally syndicated weekly National Public Radio show, It’s Your World. From 2007 to 2008, she served as acting CEO of The Elders, chaired by Archbishop Desmond Tutu. In 2008, Ms. Wales also chaired the Poverty Alleviation Track for the Clinton Global Initiative. Previously, she served in the Clinton Administration as Special Assistant to the President, senior director of the National Security Council, and associate director of the White House Office of Science and Technology Policy. She chaired the international security programs at the Carnegie Corporation of New York and the W. Alton Jones Foundation, and directed the Project on World Security at the Rockefeller Brothers Fund. During her tenure as national executive director of the Physicians for Social Responsibility, the organization’s international arm received the 1985 Nobel Peace Prize.
Rebecca Weintraub, M.D., is an assistant professor in the Department of Global Health and Social Medicine at Harvard Medical School and an associate physician at Brigham and Women’s Hospital. She serves as faculty director of the Global Health Delivery Project at Harvard and associate director of the Harvard Global Health Institute. She has led the
publication of more than 35 Harvard Business School case studies with Harvard Business Publishing, and taught at more than 300 schools of medicine, public health, and business. Since 2008, Dr. Weintraub has led GHDonline.org, a network of virtual communities that connects more than 14,000 health professionals from more than 120 countries and 5,000 organizations. Her research on value-generating strategies in global health has been funded by the Agency for Healthcare Research and Quality, The Global Fund, The Pershing Square Foundation, and The Bill & Melinda Gates Foundation.
Dr. Weintraub co-founded Jumpstart, a national service program reaching more than 50,000 preschoolers and their communities. She serves as a technical advisor to Ashoka, promoting the work of health entrepreneurs, and as a board member of the Novartis Foundation and several other nongovernmental organizations. In 2014, Dr. Weintraub was honored as a Young Global Leader by the World Economic Forum and is currently serving as a Fellow at the Berkman Center for Internet and Society. Dr. Weintraub graduated from Yale University and Stanford School of Medicine, and completed her medical training at Brigham and Women’s Hospital.
David Wofford, vice president of Meridian Group International, Inc., in Washington, DC, implements the RAISE Health Initiative, which improves the health of women and men factory and agriculture workers in developing countries through changes in global and corporate policies and workplace practices. RAISE Health is a major activity under the U.S. Agency for International Development (USAID)–funded Evidence Project, managed by the Population Council. Since 2006, he has worked on several USAID-funded projects focused on worker and women’s health in corporate supply chains. Previously, Mr. Wofford worked at the International Finance Corporation on its social and environmental performance standards and its Doing Business initiative. He has also served in senior positions in the U.S. government, including the Overseas Private Investment Corporation, an agency that supports investments by American companies in developing countries and at the White House.
This page intentionally left blank.
